A novel cryptic exon in intron 3 of the dystrophin gene was incorporated into dystrophin mRNA with a single nucleotide deletion in exon 5
- PMID: 12166656
- DOI: 10.1007/s100380200023
A novel cryptic exon in intron 3 of the dystrophin gene was incorporated into dystrophin mRNA with a single nucleotide deletion in exon 5
Abstract
The dystrophin gene, which is mutated in Duchenne muscular dystrophy, is the largest human gene. A full spectrum of the gene transcripts has not been fully elucidated yet, although two cryptic exons have so far been identified in the 5' region of the dystrophin gene. Here, a novel dystrophin mRNA containing a 62-nucleotide insertion between exons 3 and 4 was identified in lymphocytes from a Japanese Duchenne muscular dystrophy patient with a single nucleotide deletion in exon 5. The inserted 62-nucleotide sequence was found to be homologous to part of intron 3 and it was revealed that the insertion possessed branch point and both acceptor and donor splice site consensus sequences perfectly. Therefore, the 62-bp insertion sequence was considered to be a novel exon and was designated as exon 3a. However, this insertion was not present in the patient's muscle and 12 different normal tissues that were screened. The physiological role of the novel cryptic exon remains to be clarified.
Similar articles
-
Novel cryptic exons identified in introns 2 and 3 of the human dystrophin gene with duplication of exons 8-11.Kobe J Med Sci. 2006;52(3-4):61-75. Kobe J Med Sci. 2006. PMID: 16849873
-
A novel cryptic exon in intron 2 of the human dystrophin gene evolved from an intron by acquiring consensus sequences for splicing at different stages of anthropoid evolution.Biochem Biophys Res Commun. 2000 Jan 7;267(1):321-8. doi: 10.1006/bbrc.1999.1962. Biochem Biophys Res Commun. 2000. PMID: 10623618
-
Two alternative exons can result from activation of the cryptic splice acceptor site deep within intron 2 of the dystrophin gene in a patient with as yet asymptomatic dystrophinopathy.Hum Genet. 2003 Feb;112(2):164-70. doi: 10.1007/s00439-002-0854-8. Epub 2002 Oct 31. Hum Genet. 2003. PMID: 12522557
-
Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations.Hum Mutat. 2009 Mar;30(3):293-9. doi: 10.1002/humu.20918. Hum Mutat. 2009. PMID: 19156838 Review.
-
Pseudoexons of the DMD Gene.J Neuromuscul Dis. 2020;7(2):77-95. doi: 10.3233/JND-190431. J Neuromuscul Dis. 2020. PMID: 32176650 Free PMC article. Review.
Cited by
-
DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein-Taybi syndrome (RSTS) and in another patient with incomplete RSTS.Hum Genet. 2005 Sep;117(5):485-93. doi: 10.1007/s00439-005-1331-y. Epub 2005 Jul 14. Hum Genet. 2005. PMID: 16021471
-
Normal and altered pre-mRNA processing in the DMD gene.Hum Genet. 2017 Sep;136(9):1155-1172. doi: 10.1007/s00439-017-1820-9. Epub 2017 Jun 9. Hum Genet. 2017. PMID: 28597072 Review.
-
Whole dystrophin gene analysis by next-generation sequencing: a comprehensive genetic diagnosis of Duchenne and Becker muscular dystrophy.Mol Genet Genomics. 2014 Oct;289(5):1013-21. doi: 10.1007/s00438-014-0847-z. Epub 2014 Apr 27. Mol Genet Genomics. 2014. PMID: 24770780
-
A novel cryptic exon identified in the 3' region of intron 2 of the human dystrophin gene.J Hum Genet. 2005;50(8):425-433. doi: 10.1007/s10038-005-0272-6. Epub 2005 Aug 30. J Hum Genet. 2005. PMID: 16133659
-
Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing.Front Genet. 2022 Jan 24;12:806946. doi: 10.3389/fgene.2021.806946. eCollection 2021. Front Genet. 2022. PMID: 35140743 Free PMC article.